Bleichroeder LP - 04 Feb 2022 Form 4 Insider Report for DUOS TECHNOLOGIES GROUP, INC. (DUOT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Feb 2022, 15:13:54 UTC
Prior SEC filing
12 Jan 2022
Next SEC filing
03 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Michael M. Kellen, Chairman and CO-CEO of Bleichroeder LP

Key filing fact

Bleichroeder LP filed Form 4 for DUOS TECHNOLOGIES GROUP, INC. (DUOT) on 08 Feb 2022.

Key facts

  • This page summarizes Bleichroeder LP's Form 4 filing for DUOS TECHNOLOGIES GROUP, INC. (DUOT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Feb 2022, 15:13.

Change

  • Previous filing in this sequence was filed on 12 Jan 2022.
  • Current net transaction value: +$1,500,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DUOT transaction

Common Stock

Purchase

Transaction value
$1,500,000
Shares
+375,000
Change %
+41%
Price
$4.00
Shares after
1,283,162
Date
04 Feb 2022
Ownership
See footnote
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .